CNSX:TRULPharmaceuticals
Trulieve Cannabis (CNSX:TRUL): Losses Have Grown 41% Annually With Slower Revenue Growth Than Peers
Trulieve Cannabis (CNSX:TRUL) remains unprofitable, with losses accelerating at an average of 41% per year over the past five years. Although revenue is forecast to grow 2.6% annually, this pace trails the broader Canadian market’s projected 5.1% growth rate. Despite no improvement in profit margins, some investors may see value given the shares trade at CA$9.3, which is well below a fair value estimate of CA$69.2. However, major risks around profitability and growth remain top of mind.
See...